Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Viral Inactivation Market Value Expansion And Long-Term Growth Outlook

The market dedicated to viral inactivation has experienced substantial expansion recently. Projections indicate a rise from $5.47 billion in 2025 to $6.05 billion in 2026, demonstrating a compound annual growth rate of 10.6%. Key drivers behind this historical growth trajectory include a surge in the production of plasma-derived therapeutics, an increase in the manufacturing capabilities for monoclonal antibodies, heightened scrutiny from regulatory bodies concerning viral safety protocols, the broadening of biopharmaceutical production infrastructure, and a greater prevalence in the utilization of solvent detergent techniques.

The viral inactivation sector is poised for substantial expansion over the coming years, with projections indicating it will reach a value of $9.17 billion by 2030, driven by a compound annual growth rate (CAGR) of 10.9%. This projected surge is fueled by several key factors, including a heightened need for biologics and biosimilars, increased funding directed towards sophisticated bioprocessing infrastructure, a greater emphasis on continuous manufacturing practices, wider implementation of automated quality assurance mechanisms, and the broadening scope of vaccine development pipelines. During this forecast period, prominent trends are expected to include a more widespread embrace of automated viral inactivation technologies, a growing emphasis on rigorously validated virus safety protocols, the increasing utilization of continuous flow inactivation techniques, the further proliferation of single-use bioprocessing solutions, and a stronger commitment to ensuring process consistency and regulatory adherence.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10401&type=smp

Viral Inactivation Market Growth Factors: Which Forces Are Supporting Market Expansion?

The increasing prevalence of diverse infectious diseases is anticipated to stimulate expansion within the viral inactivation market. These diseases, characterized by their ability to spread between individuals through contaminated food and drink, or via microorganisms like viruses, bacteria, fungi, and parasites, necessitate effective control measures. Viral inactivation plays a crucial role in public health initiatives by employing physical and chemical agents to neutralize viruses, thereby curbing the transmission of viral contagions and consequently fostering market growth. For example, as reported by the Centers for Disease Control and Prevention in March 2024, tuberculosis cases in the US saw a rise from 8,320 in 2022 to 9,615 in 2023, marking an increment of 1,295 cases, with the incidence rate climbing from 2.5 per 100,000 people in 2022 to 2.9 in 2023. This surge in various infectious disease occurrences directly contributes to the upward trajectory of the viral inactivation market.

Viral Inactivation Market Segment Outlook: Which Categories Are Expanding The Fastest?

The viral inactivation market covered in this report is segmented –

1) By Product: Kits And Reagents, Systems, Services

2) By Method: Solvent Detergent Method, pH Adjustment Method, Pasteurization, Other Methods

3) By Application: Vaccines And Therapeutics, Tissues And Tissue Products, Blood And Blood Products, Other Applications

4) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Blood Banks, Hospital, Academic Research Institutes, Other End Users

Subsegments:

1) By Kits And Reagents: Viral Inactivation Kits, PCR Reagents, Antibodies and Enzymes

2) By Systems: Automated Viral Inactivation Systems, Batch Viral Inactivation Systems, Continuous Flow Systems

3) By Services: Viral Testing Services, Validation Services, Consulting Services

Viral Inactivation Market Industry Trends: What Changes Are Reshaping Demand?

Key players within the viral inactivation sector are concentrating on the integration of cutting-edge viral clearance technologies to bolster the safety of biological products, ensure adherence to regulations, and optimize operational workflows. These sophisticated methods, which neutralize viruses via chemical, physical, or filtration approaches, facilitate achievements such as validating log reduction, guaranteeing regulatory-compliant viral safety, and expediting crucial decisions throughout the biologics development lifecycle. Illustratively, in May of 2025, Northway Biotech, a contract development and manufacturing organization (CDMO) based in Lithuania, introduced its Full-Service Viral Clearance Studies (VCS). This cutting-edge viral clearance solution is engineered to accelerate safety validation for protein biologics and gene therapies, boasting multiple identical BSL-2 laboratories to support high-throughput operations, BSL-3 testing capacities, and a turnaround time of less than 10 weeks for complete, regulatory-compliant viral clearance results, substantially quicker than typical industry timelines. This enhanced service empowers biopharma clientele by improving development velocity, bolstering cost management, and advancing their preparedness for regulatory scrutiny.

Viral Inactivation Market Key Companies And Competitive Benchmarking

Major companies operating in the viral inactivation market are Merck & Co. Inc., Sartorius AG, Texcell SA, SGS SA, Charles River Laboratories Inc., Clean Cells SAS, Rad Source Technologies, WuXi AppTec, Sigma-Aldrich Co. LLC, Thermo Fisher Scientific Inc., Macopharma, Cerus Corporation, TERUMO BCT INC., Pall Corporation And Eurofins Scientific, Cytiva, Viral Inactivated Plasma Systems SA, Eurofins Scientific SE, Lonza Group AG, Avantor Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG

Access The Complete Viral Inactivation Market Report:

https://www.thebusinessresearchcompany.com/report/viral-inactivation-global-market-report

Viral Inactivation Market Geographic Analysis: Where Is Demand Growing The Fastest?

North Americawas the largest region in the viral inactivation market in 2025. Asia-pacific is expected to be the fastest-growing region in the global viral inactivation market during the forecast period. The regions covered in the viral inactivation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model